HC Wainwright & Co. analyst Kevin Dede downgrades Argo Blockchain (NASDAQ:ARBK) from Buy to Neutral.
Cantor Fitzgerald Downgrades Global Blood Therapeutics to Neutral, Lowers Price Target to $68.5
Cantor Fitzgerald downgrades Global Blood Therapeutics (NASDAQ:GBT) from Overweight to Neutral and lowers the price target from $75 to $68.5.